EX-4.7



 Exhibit 4.7 

WARRANT 
 THE SECURITIES
REPRESENTED BY THIS WARRANT HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES HAVE BEEN ACQUIRED FOR INVESTMENT AND MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED
IN THE ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT FOR THE SECURITIES UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS, OR AN OPINION OF COUNSEL IN A FORM REASONABLY SATISFACTORY TO THE ISSUER THAT REGISTRATION IS
NOT REQUIRED UNDER SAID ACT OR APPLICABLE STATE SECURITIES LAWS OR UNLESS SOLD PURSUANT TO RULE 144 UNDER SAID ACT. NOTWITHSTANDING THE FOREGOING, THIS WARRANT MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT. 

 
  

WARRANT TO PURCHASE PREFERRED STOCK 

 

			
	Warrant No.: [            ]		Number of Shares: [                ]
			Warrant Exercise Price: $6.15
	Date of Issuance: [                    ]		Expiration Date: [                    ]

 SynCardiaSystems, Inc., a Delaware corporation (the “Company”), hereby certifies that, for
[                            ] United States Dollars ($[        ])
and other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged,
[                            ] (the “Holder”), the registered Holder hereof or its permitted
assigns, is entitled, subject to the terms set forth below, to purchase from the Company upon surrender of this Warrant, at any time or times on or after the date hereof (the “Effective Date”), but not after 11:59 P.M. Eastern Time on the
Expiration Date (as defined herein) the number of fully paid and nonassessable shares of the Preferred Stock (as defined herein) of the Company (the “Warrant Shares”) set forth above at the exercise price per share provided in
Section 1(a)(xii) below or as subsequently adjusted. For purposes of this Warrant, in determining the number of outstanding shares of Preferred Stock, a Holder may rely on the number of outstanding shares of Preferred Stock as reflected in
(1) the Company’s most recent Form 10-QSB or Form 10-KSB, if any, (2) a more recent public announcement by the Company or (3) any other notice by the Company or its transfer agent setting forth the number of shares of Preferred
Stock outstanding. Upon the written request of the Holder, the Company shall promptly, but in no event later than two (2) Business Day following the receipt of such notice, confirm in writing to any such Holder the number of shares of Preferred
Stock then outstanding. In any case, the number of outstanding shares of Preferred Stock shall be determined after giving effect to the exercise of Warrants (as defined below) by such Holder and its affiliates since the date as of which such number
of outstanding shares of Preferred Stock was reported. The Holder and the Company agree that notwithstanding any terms to the contrary contained herein, the Holder shall have no right to exercise this Warrant until the Effective Date. This Warrant
is being issued to Holder as an inducement to Holder agreeing, subject to the conditions set forth in that certain
[                            ] Agreement of even date herewith between Holder and the Company (the
“[                            ] Agreement”), to make available to the Company up to
$[        ] in [                            ]








 
financing pursuant to the terms and conditions of the
[                            ] Agreement. In the event the Company does not execute an
[                            ] under the
[                            ] Agreement, this Warrant shall be void. 

Section 1. 
 (a)
Definitions. The following words and terms as used in this Warrant shall have the following meanings: 
 (i) “Approved Stock
Plan” means any employee benefit plan which has been approved by the Board of Directors of the Company, pursuant to which the Company’s securities may be issued to any employee, officer or director for services provided to the Company.

 (ii) “Business Day” means any day other than Saturday, Sunday or other day on which commercial banks in the City of New
York are authorized or required by law to remain closed. 
 (iii) “Effective Date” means the date of the issuance date of
this Warrant. 
 (iv) “Expiration Date” means the earliest of (i) the date ten (10) years from the Issuance Date
of this Warrant or, if such date falls on a Saturday, Sunday or other day on which banks are required or authorized to be closed in the City of Phoenix or the State of Arizona (a “Holiday”), the next date that is not a Holiday; and
(ii) the one (1) year anniversary of the consummation of the Company’s sale of its Common Stock or other capital stock pursuant to a registration statement under the Securities Act (other than a registration statement relating either
to sale of securities to employees of the Company pursuant to its stock option, stock purchase or similar plan or a SEC Rule 145 transaction). 

(v) “Issuance Date” means the date hereof. 

(vi)
“[                            ] Agreement” means that certain
[                            ] Agreement of even date herewith between Holder and the Company. 

(vii) “Options” means any rights, warrants or options to subscribe for or purchase Preferred Stock or Convertible
Securities. 
 (viii) “Other Securities” means (i) those options and warrants of the Company issued prior to, and
outstanding on, the Issuance Date of this Warrant, (ii) the shares of Preferred Stock issuable on exercise of such options and warrants, provided such options and warrants are not amended after the Issuance Date of this Warrant and
(iii) the shares of Preferred Stock issuable upon exercise of this Warrant. 
 (ix) “Person” means an individual, a
limited liability company, a partnership, a joint venture, a corporation, a trust, an unincorporated organization and a government or any department or agency thereof. 

  
 2 








 (x) “Preferred Stock” means (i) the Company’s Series “E”
Preferred Stock, par value $0.01 per share, and (ii) any capital stock into which such Preferred Stock shall have been changed or any capital stock resulting from a reclassification of such Preferred Stock. 

(xi) “Restated Certificate of Incorporation” means the Company’s
[                            ] Restated Certificate of Incorporation filed with the State of Delaware on
[                    ], and all amendments and restatements subsequent to the date hereof. 

(xii) “Securities Act” means the Securities Act of 1933, as amended. 

(viii) “Stockholders Agreement” means the Company’s
[                            ] Amended and Restated Stockholders’ Agreement dated as of
[                    ], as amended subsequent to the date hereof. 

(xiv) “Warrant” means this Warrant and all Warrants issued in exchange, transfer or replacement thereof. 

(xv) “Warrant Exercise Price” shall be the price set forth on page one of this Warrant or as subsequently adjusted as
provided in Section 8 hereof. 
 (xvi) “Warrant Shares” means the shares of Preferred Stock issuable at any time upon
exercise of this Warrant. 
 (b) Other Definitional Provisions. 

(i) Except as otherwise specified herein, all references herein (A) to the Company shall be deemed to include the Company’s
successors and (B) to any applicable law defined or referred to herein shall be deemed references to such applicable law as the same may have been or may be amended or supplemented from time to time. 

(ii) When used in this Warrant, the words “herein”, “hereof”, and “hereunder” and words of
similar import, shall refer to this Warrant as a whole and not to any provision of this Warrant, and the words “Section”, “Schedule”, and “Exhibit” shall refer to Sections of, and Schedules and
Exhibits to, this Warrant unless otherwise specified. 
 (iii) Whenever the context so requires, the neuter gender includes the masculine
or feminine, and the singular number includes the plural, and vice versa. 
 Section 2. Exercise of Warrant. 

(a) Subject to the terms and conditions hereof, this Warrant may be exercised by the Holder hereof then registered on the books of the
Company, pro rata as hereinafter provided, at any time on any Business Day on or after the opening of business on such Business Day, commencing with the Effective Date, and prior to 11:59 P.M. Eastern Time on the Expiration Date, by
(i) delivery of a written notice, in the form of the subscription notice attached as Exhibit A hereto (the “Exercise Notice”), of such Holder’s election to exercise this


  
 3 








 
Warrant, which notice shall specify the number of Warrant Shares to be purchased, (ii) payment to the Company of an amount equal to the Warrant Exercise Price(s) applicable to the Warrant
Shares being purchased, multiplied by the number of Warrant Shares (at the applicable Warrant Exercise Price) as to which this Warrant is being exercised (plus any applicable issue or transfer taxes) (the “Aggregate Exercise Price”)
in cash or wire transfer of immediately available funds and (iii) the surrender of this Warrant (or an indemnification undertaking with respect to this Warrant in the case of its loss, theft or destruction) to a common carrier for overnight
delivery to the Company as soon as practicable following such date. In the event of any exercise of the rights represented by this Warrant in compliance with this Section 2, the Company shall on the fifth (5th) Business Day following the
date of receipt of the Exercise Notice, the Aggregate Exercise Price and this Warrant (or an indemnification undertaking with respect to this Warrant in the case of its loss, theft or destruction) and the receipt of the representations of the Holder
specified in Section 6 hereof, if requested by the Company (the “Exercise Delivery Documents”), issue and surrender to a common carrier for overnight delivery to the address specified in the Exercise Notice, a certificate,
registered in the name of the Holder, for the number of shares of Preferred Stock to which the Holder shall be entitled pursuant to such request. Upon delivery of the Exercise Notice and Aggregate Exercise Price referred to in clause (ii) above
the Holder of this Warrant shall be deemed for all corporate purposes to have become the Holder of record of the Warrant Shares with respect to which this Warrant has been exercised. Notwithstanding any provisions herein to the contrary, if the fair
market value of one Warrant Share is greater than the Exercise Price (at the date of calculation as set forth below), in lieu of exercising this Warrant by payment of cash, the Holder may elect to receive shares equal to the value (as determined
below) of this Warrant (or the portion thereof being canceled) by surrender of this Warrant at the principal office of the Company together with the properly endorsed Notice of Exercise in which event the Company shall issue to the Holder a number
of Warrant Shares computed using the following formula: 
  

					
	X =		Y (A-B)		
			A		

  

			
	Where X =		the number of Warrant Shares to be issued to the Holder
		
	Y =		the number of Warrant Shares purchasable under the Warrant or, if only a portion of the Warrant is being exercised, that portion of the Warrant being canceled (at the date of such calculation)
		
	A =		the fair market value of one Warrant Share (at the date of such calculation)
		
	B =		Exercise Price (as adjusted to the date of such calculation)

 For purposes of the above calculation, the fair market value of one Warrant Share shall be determined by the
Company’s Board of Directors in good faith; provided, however, that in the event that this Warrant is exercised pursuant to this Section 2 in connection with the Company’s initial public offering of its Common Stock, the fair market
value per share shall be the product of (i) the per share offering price to the public of the Company’s Common Stock in the initial public offering, and (ii) the number of shares of Common Stock into which each Warrant Share is
convertible at the time of such exercise. 

  
 4 








 (b) Unless the rights represented by this Warrant shall have expired or shall have been fully
exercised, the Company shall, as soon as practicable and in no event later than five (5) Business Days after any exercise and at its own expense, issue a new Warrant identical in all respects to this Warrant exercised except it shall represent
rights to purchase the number of Warrant Shares purchasable immediately prior to such exercise under this Warrant exercised, less the number of Warrant Shares with respect to which such Warrant is exercised. 

(c) No fractional Warrant Shares are to be issued upon any pro rata exercise of this Warrant, but rather the number of Warrant Shares issued
upon such exercise of this Warrant shall be rounded up or down to the nearest whole number. 
 (d) All Warrant Shares shall be issued
subject to the terms of the Restated Certificate of Incorporation and the Stockholders Agreement. The Company’s obligation to issue any Warrant Shares pursuant to the terms of this Warrant shall be conditioned upon the Holder’s execution
of the Stockholders Agreement. Any Warrant Shares issued pursuant to this Warrant shall bear such legends required by the terms of the Stockholders Agreement. 

Section 3. Covenants as to Preferred Stock. The Company hereby covenants and agrees as follows: 

(a) This Warrant is, and any Warrants issued in substitution for or replacement of this Warrant will upon issuance be, duly authorized and
validly issued. 
 (b) All Warrant Shares which may be issued upon the exercise of the rights represented by this Warrant will, upon
issuance, be validly issued, fully paid and nonassessable and free from all taxes, liens and charges with respect to the issue thereof. 

(c) The Company will at all times have authorized and reserved at least one hundred percent (100%) of the number of shares of Preferred
Stock needed to provide for the exercise of the rights then represented by this Warrant and the par value of said shares will at all times be less than or equal to the applicable Warrant Exercise Price. If at any time the Company does not have a
sufficient number of shares of Preferred Stock authorized and available, then the Company shall call and hold a special meeting of its stockholders within sixty (60) days of that time for the sole purpose of increasing the number of authorized
shares of Preferred Stock. 
 (d) If at any time after the date hereof the Company shall file a registration statement, the Company shall
include the shares of Common Stock issuable upon conversion of the Warrant Shares issuable to the Holder, pursuant to the terms of this Warrant and shall maintain, so long as any shares of its capital stock shall be so listed, such listing of all
shares of capital stock issuable upon conversion of the Warrant Shares from time to time issuable upon the exercise of this Warrant; and the Company shall so list on each national securities exchange or automated quotation system, as the case may
be, and shall maintain such listing of, any other shares of capital stock of the Company issuable upon the exercise of this Warrant if and so long as any shares of the same class shall be listed on such national securities exchange or automated
quotation system. 

  
 5 








 (e) The Company will not, by amendment of its Restated Certificate of Incorporation or through
any reorganization, transfer of assets, consolidation, merger, dissolution, issue or sale of securities, or any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms to be observed or performed by it
hereunder, but will at all times in good faith assist in the carrying out of all the provisions of this Warrant and in the taking of all such action as may reasonably be requested by the Holder of this Warrant in order to protect the exercise
privilege of the Holder of this Warrant against dilution or other impairment, consistent with the tenor and purpose of this Warrant. The Company will not increase the par value of any shares of Preferred Stock receivable upon the exercise of this
Warrant above the Warrant Exercise Price then in effect, and (ii) will take all such actions as may be necessary or appropriate in order that the Company may validly and legally issue fully paid and nonassessable shares of Preferred Stock upon
the exercise of this Warrant. 
 (f) This Warrant will be binding upon any entity succeeding to the Company by merger, consolidation or
acquisition of all or substantially all of the Company’s assets. 
 Section 4. Taxes. The Company will pay all taxes (other
than taxes based upon income) and other governmental charges that may be imposed with respect to the issuance or delivery of shares of Preferred Stock upon exercise of this Warrant, other than any tax or other charge imposed in connection with any
transfer involved in the issue and delivery of shares of Preferred Stock in a name other than that of the Holder. 
 Section 5.
Warrant Holder Not Deemed a Stockholder. Except as otherwise specifically provided herein, no Holder, as such, of this Warrant shall be entitled to vote or receive dividends or be deemed the holder of shares of capital stock of the Company
for any purpose, nor shall anything contained in this Warrant be construed to confer upon the Holder hereof, as such, any of the rights of a stockholder of the Company or any right to vote, give or withhold consent to any corporate action (whether
any reorganization, issue of stock, reclassification of stock, consolidation, merger, conveyance or otherwise), receive notice of meetings, receive dividends or subscription rights, or otherwise, prior to the issuance to the Holder of the Warrant
Shares which he or she is then entitled to receive upon the due exercise of this Warrant. In addition, nothing contained in this Warrant shall be construed as imposing any liabilities on such Holder to purchase any securities (upon exercise of this
Warrant or otherwise) or as a stockholder of the Company, whether such liabilities are asserted by the Company or by creditors of the Company. Notwithstanding this Section 5, the Company will provide the Holder of this Warrant with copies of
the same notices and other information given to the other holders of Preferred Stock contemporaneously with the giving thereof to such holders. 

Section 6. Representations of Holder. The Holder of this Warrant, by the acceptance hereof, represents that it is acquiring this
Warrant and the Warrant Shares for its own account for investment only and not with a view towards, or for resale in connection with, the public sale or distribution of this Warrant or the Warrant Shares, except pursuant to sales registered or
exempted under the Securities Act; provided, however, that by making the representations herein, the Holder does not agree to hold this Warrant or any of the Warrant Shares for any minimum or other specific term and reserves the right to dispose of
this Warrant and the Warrant Shares at any time in accordance with or pursuant to a registration statement or an exemption 

  
 6 








 
under the Securities Act and other applicable securities laws. The Holder of this Warrant further represents, by acceptance hereof, that, as of this date, such Holder is an “accredited
investor” as such term is defined in Rule 501(a)(1) of Regulation D promulgated by the Securities and Exchange Commission under the Securities Act (an “Accredited Investor”). Upon exercise of this Warrant the Holder shall, if
requested by the Company, confirm in writing, in a form satisfactory to the Company, that the Warrant Shares so purchased are being acquired solely for the Holder’s own account and not as a nominee for any other party, for investment, and not
with a view toward distribution or resale and that such Holder is an Accredited Investor. If such Holder cannot make such representations because they would be factually incorrect, it shall be a condition to such Holder’s exercise of this
Warrant that the Company receive such other representations as the Company considers reasonably necessary to assure the Company that the issuance of its securities upon exercise of this Warrant shall not violate any United States or state securities
laws. 
 Section 7. Ownership and Transfer. 

(a) The Company shall maintain at its principal executive offices (or such other office or agency of the Company as it may designate by notice
to the Holder hereof), a register for this Warrant, in which the Company shall record the name and address of the person in whose name this Warrant has been issued, as well as the name and address of each transferee. The Company may treat the person
in whose name any Warrant is registered on the register as the owner and Holder thereof for all purposes, notwithstanding any notice to the contrary, but in all events recognizing any transfers made in accordance with the terms of this Warrant 

(b) The Company agrees that, notwithstanding anything to the contrary contained herein and subject only to compliance with applicable federal
and state securities laws, the Holder shall be entitled to transfer all or any portion of this Warrant or of the Warrant Shares to an Affiliated Entity of the Holder. As used in this Subsection 7(b), an “Affiliated Entity” of a Holder
means any general or limited partner of such Holder, if such Holder is a partnership, any manager or member of such Holder, if such Holder is a limited liability company, or any person or entity that, directly or indirectly, thorough one or more
intermediaries, controls, is controlled by, or in under common control with, such Holder and includes, without limitation,
[                            ]. The Holder agrees not to make any disposition of the Warrant or all or any
portion of the Warrant Shares to an Affiliated Entity or to any other Person unless and until (i) the Holder shall have notified the Company of the proposed disposition and shall have furnished the Company with a reasonably detailed statement
of the circumstances surrounding the proposed disposition and (ii) the transferee has agreed in writing for the benefit of the Company to be bound by the terms of this Warrant and any other stockholder or similar agreement among substantially
all other holders of Common Stock as reasonably requested by the Company, including, without limitation, the Stockholders Agreement. 
 (c)
Except for transfers permitted under Subsection (b) of this Section 7, the Holder agrees not to make any disposition of the Warrant or all or any portion of the Warrant Shares or the shares issuable upon conversion thereof unless and until
the transferee has agreed in writing for the benefit of the Company to be bound by the terms of this Warrant and 

  
 7 








 
any other stockholder or similar agreement among substantially all other holders of Preferred Stock or Common Stock as reasonably requested by the Company, including, without limitation, the
Stockholders Agreement; and 
 (i) there is then in effect a registration statement under the Securities Act covering such proposed
disposition and such disposition is made in accordance with such registration statement; or 
 (ii) the Holder shall have notified the
Company of the proposed disposition and shall have furnished the Company with a reasonably detailed statement of the circumstances surrounding the proposed disposition, and if reasonably requested by the Company, the Holder shall have furnished the
Company with an opinion of counsel, reasonably satisfactory to the Company, that such disposition will not require registration of such shares under the Securities Act (it is agreed that the Company will not require opinions of counsel for
transactions made pursuant to Rule 144 except in extraordinary circumstances). 
 Section 8. Adjustment of Warrant Exercise Price
and Number of Shares. The Warrant Exercise Price and the number of shares of Preferred Stock issuable upon exercise of this Warrant shall be adjusted from time to time as follows: 

(a) Adjustment of Warrant Exercise Price upon Subdivision or Combination of Preferred Stock. If the Company at any time after the date
of issuance of this Warrant subdivides (by any stock split, stock dividend, recapitalization or otherwise) one or more classes of its outstanding shares of Preferred Stock into a greater number of shares, any Warrant Exercise Price in effect
immediately prior to such subdivision will be proportionately reduced and the number of shares of Preferred Stock obtainable upon exercise of this Warrant will be proportionately increased. If the Company at any time after the date of issuance of
this Warrant combines (by combination, reverse stock split or otherwise) one or more classes of its outstanding shares of Preferred Stock into a smaller number of shares, any Warrant Exercise Price in effect immediately prior to such combination
will be proportionately increased and the number of Warrant Shares issuable upon exercise of this Warrant will be proportionately decreased. Any adjustment under this Section 8(a) shall become effective at the close of business on the date the
subdivision or combination becomes effective. 
 (b) Distribution of Assets. If the Company shall declare or make any dividend or
other distribution of its assets (or rights to acquire its assets) to holders of Preferred Stock, by way of return of capital or otherwise (including, without limitation, any distribution of cash, stock or other securities, property or options by
way of a dividend, spin off, reclassification, corporate rearrangement or other similar transaction) (a “Distribution”), at any time after the issuance of this Warrant, then, in each such case: 

(i) any Warrant Exercise Price in effect immediately prior to the close of business on the record date fixed for the determination of holders
of Preferred Stock entitled to receive the Distribution shall be reduced, effective as of the close of business on such record date, to a price determined by multiplying such Warrant Exercise Price by a fraction of which (A) the numerator shall
be the value of the Preferred Stock on the Business Day immediately preceding such record date minus the value of the Distribution (as determined in 

  
 8 








 
good faith by the Company’s Board of Directors) applicable to one share of Preferred Stock, and (B) the denominator shall be the value of the Preferred Stock on the Business Day
immediately preceding such record date. The value of the Preferred Stock for such purposes shall be determined by an independent outside accountant selected by the Holder and the Company; and 

(ii) either (A) the number of Warrant Shares obtainable upon exercise of this Warrant shall be increased to a number of shares equal to
the number of shares of Preferred Stock obtainable immediately prior to the close of business on the record date fixed for the determination of holders of Preferred Stock entitled to receive the Distribution multiplied by the reciprocal of the
fraction set forth in the immediately preceding clause (i), or (B) in the event that the Distribution is of common stock of a company whose common stock is traded on a national securities exchange or a national automated quotation system, then
the Holder of this Warrant shall receive an additional warrant to purchase Preferred Stock, the terms of which shall be identical to those of this Warrant, except that such warrant shall be exercisable into the amount of the assets that would have
been payable to the Holder of this Warrant pursuant to the Distribution had the Holder exercised this Warrant immediately prior to such record date and with an exercise price equal to the amount by which the exercise price of this Warrant was
decreased with respect to the Distribution pursuant to the terms of the immediately preceding clause (i). 
 (c) Issuance of Preferred
Stock. If at any time or from time to time, the Company shall issue or sell Preferred Stock or rights, options, warrants or other securities convertible into Preferred Stock, excluding those rights, options, warrants or other securities
convertible into Preferred Stock outstanding as of the date hereof, at a price per share (the “Sale Price”) that is lower than the then current Warrant Exercise Price (a “Series E Preferred Issuance”), then the Warrant Exercise
Price shall thereupon be reduced to the Sale Price and the holder of this Warrant shall thereafter, on the exercise hereof as provided in Section 2, be entitled to receive that number of shares of Preferred Stock determined by multiplying the
number of shares of Preferred Stock that would otherwise (but for the provisions of this Section 8(c)) be issuable on such exercise, by a fraction of which (i) the numerator is the Warrant Exercise Price that would otherwise (but for the
provisions of this Section 8(c)) be in effect, and (ii) the denominator is the Warrant Exercise Price as adjusted pursuant to this Section 8(c). Such adjustment shall be made upon each Series E Preferred Issuance, and shall become
effective immediately and retroactive to the record date for the determination of stockholders issued the Preferred Stock or entitled to receive such rights, options, warrants or convertible securities in connection with such Preferred Issuance.

 If there is an adjustment to the Warrant Exercise Price pursuant to the immediately preceding paragraph as a result of the issuance of
rights, options, warrants or other securities convertible into Preferred Stock, then upon the termination of the right to convert or exchange such securities or the right to acquire Preferred Stock, the Warrant Exercise Price shall be readjusted to
such Warrant Exercise Price as would have been obtained had the adjustments made upon the issuance of such convertible or exchangeable securities been made upon the basis of the delivery of only the number of shares of Preferred Stock actually
delivered upon conversion or exchange of such securities or the exercise of the options or warrants and upon the basis of the consideration actually received by the Company (determined as provided in paragraph (d) immediately below) for such
securities. Such a readjustment shall not affect the 

  
 9 








 
number of shares issued upon the exercise of any Warrants prior to the date the readjustment is made. 

(d) Valuation of consideration. For purposes of any computation respecting consideration received pursuant to paragraph
(c) hereof, the following shall apply: 
 (i) in the case of the issuance of shares of Preferred Stock for cash, the consideration
shall be the amount of such cash, provided that in no case shall any deductions be made for any commissions, discounts or other expenses incurred by the Company for any underwriting of the issue or otherwise in connection therewith; 

(ii) in the case of the issuance of shares of Preferred Stock for a consideration in whole or in part other than cash, the consideration
other than cash shall be deemed to be the fair market value thereof as determined by the Company’s Board of Directors in good faith; and (iii) in the case of the issuance of securities convertible into or exchangeable for shares of
Preferred Stock, the aggregate consideration received therefor shall be deemed to be the consideration received by the Company for the issuance of such securities plus the additional minimum consideration, if any, to be received by the Company upon
the conversion or exchange thereof (the consideration in each case to be determined in the same manner as provided in clauses (i) and (ii) of this paragraph (d)). 

(e) Definition of shares of Preferred Stock. For the purposes of this Section 8, the term “shares of Preferred Stock”
shall mean (i) the class of stock designated as the Preferred Stock of the Company at the date of this Agreement as defined in Section 1(a)(x) hereof or (ii) any other class of stock resulting from changes or reclassifications of such
shares consisting solely of changes in par value, or from par value to no par value, or from no par value to par value. In the event that at any time, as a result of an adjustment made pursuant to paragraph (b) above, the Holders shall become
entitled to purchase any shares of the Company other than shares of Preferred Stock, thereafter the number of such other shares so purchasable upon exercise of each Warrant and the Warrant Exercise Price of such shares shall be subject to adjustment
from time to time in a manner and on terms as nearly equivalent as practicable to the provisions with respect to the Warrant Shares contained in Section 8 as they would have been applied to the Warrant Shares. 

(f) Minimum adjustment. No adjustment in the number of shares purchasable hereunder shall be required unless such adjustment would
require an increase or decrease of at least one half (1/2) of one percent (1%) in the number of shares purchasable upon the exercise of each Warrant; provided, however, that any adjustments which by reason of this paragraph (f) are
not required to be made shall be carried forward and taken into account in any subsequent adjustment or upon any exercise of a Warrant. 

(g) Certain Events. If any event occurs of the type contemplated by the provisions of this Section 8 but not expressly provided
for by such provisions (including, without limitation, the granting of stock appreciation rights, phantom stock rights or other rights with equity features, in each case, that relate to the Preferred Stock), then the Company’s Board of
Directors will make an appropriate adjustment in the Warrant Exercise Price and the number of shares of Preferred Stock obtainable upon exercise of this Warrant so as to protect the rights of 

  
 10 








 
the Holders of the Warrants; provided that no such adjustment pursuant to this Section 8(j) will increase the Warrant Exercise Price or decrease the number of shares of Preferred Stock
obtainable as otherwise determined pursuant to this Section 8. 
 (h) Notices. 

(i) Immediately upon any adjustment of the Warrant Exercise Price, the Company will give written notice thereof to the Holder of this
Warrant, setting forth in reasonable detail, and certifying, the calculation of such adjustment. 
 (ii) The Company will give written
notice to the Holder of this Warrant at least ten (10) days prior to the date on which the Company closes its books or takes a record (A) with respect to any dividend or distribution upon the Preferred Stock, (B) with respect to any
pro rata subscription offer to Holders of Preferred Stock or (C) for determining rights to vote with respect to any Organic Change (as defined below), dissolution or liquidation, provided that such information shall be made known to the public
prior to or in conjunction with such notice being provided to such Holder. 
 (iii) The Company will also give written notice to the Holder
of this Warrant at least ten (10) days prior to the date on which any Organic Change, dissolution or liquidation will take place, provided that such information shall be made known to the public prior to or in conjunction with such notice being
provided to such Holder. 
 Section 9. Purchase Rights; Reorganization, Reclassification, Consolidation, Merger or Sale. 

(a) In addition to any adjustments pursuant to Section 8 above, if at any time the Company grants, issues or sells any Options, Convertible Securities or
rights to purchase stock, warrants, securities or other property pro rata to the record holders of any class of Preferred Stock (the “Purchase Rights”) that are not otherwise waived by such holders in accordance with the
Company’s current Restated Certificate of Incorporation on file with the Secretary of State of the State of Delaware, then the Holder of this Warrant will be entitled to acquire, upon the terms applicable to such Purchase Rights, the aggregate
Purchase Rights which such Holder could have acquired if such Holder had held the number of shares of Preferred Stock acquirable upon complete exercise of this Warrant immediately before the date on which a record is taken for the grant, issuance or
sale of such Purchase Rights, or, if no such record is taken, the date as of which the record Holders of Preferred Stock are to be determined for the grant, issue or sale of such Purchase Rights. 

(b) Any recapitalization, reorganization, reclassification, consolidation, merger, sale of all or substantially all of the Company’s
assets to another Person or other transaction in each case which is effected in such a way that Holders of Preferred Stock are entitled to receive (either directly or upon subsequent liquidation) stock, securities or assets with respect to or in
exchange for Preferred Stock is referred to herein as an “Organic Change.” Prior to the consummation of any (i) sale of all or substantially all of the Company’s assets to an acquiring Person or (ii) other Organic
Change following which the Company is not a surviving entity, the Company will secure from the Person purchasing such assets or the successor 

  
 11 








 
resulting from such Organic Change (in each case, the “Acquiring Entity”) a written agreement (in form and substance reasonably satisfactory to the Holders of Warrants
representing at least two-thirds (2/3rds) of the Warrant Shares issuable upon exercise of the Warrants then outstanding (such Holders, the “Requisite Holders”)) to deliver to each Holder of Warrants in exchange for such Warrants, a
security of the Acquiring Entity evidenced by a written instrument substantially similar in form and substance to this Warrant and reasonably satisfactory to the Holders of the Warrants (including an adjusted warrant exercise price equal to the
value for the Preferred Stock reflected by the terms of such consolidation, merger or sale, and exercisable for a corresponding number of shares of Preferred Stock acquirable and receivable upon exercise of the Warrants without regard to any
limitations on exercise, if the value so reflected is less than any Applicable Warrant Exercise Price immediately prior to such consolidation, merger or sale). Notwithstanding the previous sentence of this Subsection (b), in the event as of the date
of the consummation of any (i) sale of all or substantially all of the Company’s assets to an acquiring Person or (ii) other Organic Change following which the Company is not a surviving entity, the fair market value of the Warrant
Shares, as determined by the Company’s Board of Directors in good faith, is greater than three times the then Warrant Exercise Price and the Holder is given the right to exercise the Warrants prior to or concurrently with such consummation, the
Acquiring Entity may elect not to deliver to each Holder of Warrants in exchange for such Warrants, a security of the Acquiring Entity and each Holder shall be required to exercise the Warrants in connection with such transaction. Prior to the
consummation of any other Organic Change, the Company shall make appropriate provision (in form and substance reasonably satisfactory to the Requisite Holders) to insure that each of the Holders of the Warrants will thereafter have the right to
acquire and receive in lieu of or in addition to (as the case may be) the Warrant Shares immediately theretofore issuable and receivable upon the exercise of such Holder’s Warrants without regard to any limitations on exercise), such shares of
stock, securities or assets that would have been issued or payable in such Organic Change with respect to or in exchange for the number of Warrant Shares which would have been issuable and receivable upon the exercise of such Holder’s Warrant
as of the date of such Organic Change (without taking into account any limitations or restrictions on the exercisability of this Warrant). 

Section 10. Mutilated or Destroyed Warrant. If this Warrant is lost, stolen, mutilated or destroyed, the Company shall promptly,
on receipt of an indemnification undertaking (or, in the case of a mutilated Warrant, the Warrant), issue a new Warrant of like denomination and tenor as this Warrant so lost, stolen, mutilated or destroyed. 

Section 11. Notice. Any notices, consents, waivers or other communications required or permitted to be given under the terms of
this Warrant must be in writing and will be deemed to have been delivered: (i) upon receipt, when delivered personally; (ii) upon receipt, when sent by facsimile (provided confirmation of receipt is received by the sending party
transmission is mechanically or electronically generated and kept on file by the sending party); or (iii) one Business Day after deposit with a nationally recognized overnight delivery service, in each case properly addressed to the party to
receive the same. The addresses and facsimile numbers for such communications shall be: 
  

					
	If to Holder:		[
                                        		
			
                                        		
			
                                        		


  
 12 









					
			
                                        		
			
                                        		
			
                                        ]		

  

					
	With Copy to:		[
                                    
			
                                        

			
                                        

			
                                        

			
                                        

			                                     
]
		
	If to the Company, to:		SynCardiaSystems, Inc.
			1992 East Silverlake Road
			Tucson, Arizona 85713
			Attention:		Rodger Ford
			Telephone:
			Facsimile:
		
	With a copy to:		[                                    

		
			
                                    
			                                     
]

 If to a Holder of this Warrant, to it at the address and facsimile number set forth on Exhibit C hereto, with copies to
such Holder’s representatives as set forth on Exhibit C, or at such other address and facsimile as shall be delivered to the Company upon the issuance or transfer of this Warrant. Each party shall provide five days’ prior written
notice to the other party of any change in address or facsimile number. Written confirmation of receipt (A) given by the recipient of such notice, consent, facsimile, waiver or other communication, or (B) provided by a nationally
recognized overnight delivery service shall be rebuttable evidence of personal service, receipt by facsimile or receipt from a nationally recognized overnight delivery service in accordance with clause (i), (ii) or (iii) above,
respectively. 
 Section 12. Date. The date of this Warrant is set forth on page 1 hereof. This Warrant, in all events, shall be
wholly void and of no effect after the close of business on the Expiration Date. 
 Section 13. Amendment and Waiver. Except as
otherwise provided herein, the provisions of the Warrants may be amended and the Company may take any action herein prohibited, or omit to perform any act herein required to be performed by it, only if the Company has obtained the written consent of
the Requisite Holders; provided that, except for Sections 8(a) and 8(d), no such action may increase the Warrant Exercise Price or decrease the number of shares or class of stock obtainable upon exercise of any Warrant without the written consent of
the Holder of such Warrant. 
 Section 14. Descriptive Headings; Governing Law. The descriptive headings of the several sections
and paragraphs of this Warrant are inserted for convenience only and do not 

  
 13 








 
constitute a part of this Warrant. All questions concerning the construction, validity, enforcement and interpretation of this Agreement shall be governed by the internal laws of the State of
Arizona, without giving effect to any choice of law or conflict of law provision or rule (whether of the State of Arizona or any other jurisdictions) that would cause the application of the laws of any jurisdictions other than the State of Arizona.
Each party hereby irrevocably submits to the exclusive jurisdiction of the state and federal courts sitting in Arizona, for the adjudication of any dispute hereunder or in connection herewith or therewith, or with any transaction contemplated hereby
or discussed herein, and hereby irrevocably waives, and agrees not to assert in any suit, action or proceeding, any claim that it is not personally subject to the jurisdiction of any such court, that such suit, action or proceeding is brought in an
inconvenient forum or that the venue of such suit, action or proceeding is improper. Each party hereby irrevocably waives personal service of process and consents to process being served in any such suit, action or proceeding by mailing a copy
thereof to such party at the address for such notices to it under this Agreement and agrees that such service shall constitute good and sufficient service of process and notice thereof. Nothing contained herein shall be deemed to limit in any way
any right to serve process in any manner permitted by law. 
 Section 15. Waiver of Jury Trial. AS A MATERIAL
INDUCEMENT FOR EACH PARTY HERETO TO ENTER INTO THIS WARRANT, THE PARTIES HERETO HEREBY WAIVE ANY RIGHT TO TRIAL BY JURY IN ANY LEGAL PROCEEDING RELATED IN ANY WAY TO THIS WARRANT AND/OR ANY AND ALL OF THE OTHER DOCUMENTS ASSOCIATED WITH THIS
TRANSACTION. 
 IN WITNESS WHEREOF, the Company has caused this Warrant to be signed as of the date first set forth above. 

 

			
	SynCardiaSystems, Inc.
		
	By:		 /s/ Michael Garippa

	Name:		Michael Garippa
	Title:		Chief Executive Officer



  
 14 








 EXHIBIT A TO WARRANT 

EXERCISE NOTICE 

TO BE EXECUTED 
 BY THE
REGISTERED HOLDER TO EXERCISE THIS WARRANT 
  

 
 The undersigned
Holder hereby exercises the right to purchase                              of the shares of Series E
Preferred Stock (“Warrant Shares”) of SynCardiaSystems, Inc., a Delaware corporation (the “Company”), evidenced by the attached Warrant (the “Warrant”). Capitalized terms used herein and not
otherwise defined shall have the respective meanings set forth in the Warrant. 
 1. Form of Warrant Exercise Price. The Holder
intends that payment of the Warrant Exercise Price shall be made as a “Cash Exercise” with respect to
                             Warrant Shares. 

2. Payment of Warrant Exercise Price. The Holder shall pay the sum of $         to the Company
in accordance with the terms of the Warrant. 
 3. Delivery of Warrant Shares. The Company shall deliver to the Holder
                 Warrant Shares in accordance with the terms of the Warrant. 

Date:                  ,          

 

			
	Name of Registered Holder
		
	By:		  

	Name:		  

	Title:		  



  
 A-1 








 EXHIBIT B TO WARRANT 

FORM OF WARRANT POWER 
 FOR VALUE
RECEIVED, the undersigned does hereby assign and transfer to                             , Federal
Identification No.            , a warrant to purchase                  shares of the Series E Preferred Stock
of SynCardiaSystems, Inc., a Delaware corporation, represented by warrant certificate no.             , standing in the name of the undersigned on the books of said corporation. The
undersigned does hereby irrevocably constitute and appoint                             , attorney to transfer
the warrants of said corporation, with full power of substitution in the premises. 
  

									
	Dated:		  
				  

					
							By:		  

							Name:		  

							Title:		  



  
 B-1